Work

The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines.

Year: 2011

Type: article

Source: PubMed

Authors: Vivian Arrias Herrera, Evelyn Zeindl-Eberhart, Andreas Jung, Rudolf Maria Huber, Albrecht Bergner

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2099373320

FWCI: 2.285

Cites: 17

Cited by: 43

Related to: 10